Quantum BioPharma

12/19/2025

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

https://globenewswire.com/news-release/2025/12/19/3208756/0/en/World-Renowned-Law-Firm-Grant-Eisenhofer-Files-Class-Action-Lawsuit-Against-Canadian-Banks-CIBC-and-RBC-Alleging-Illegal-Stock-Market-Manipulation-of-Quantum-BioPharma-Shares.html

$QNTM

12/10/2025

Most people think MS is just the immune system attacking myelin — but one of the earliest changes happens insidethe myelin itself.
A healthy myelin sheath relies on Myelin Basic Protein (MBP) to stay compact and stable.

But in MS, MBP can undergo citrullination — a chemical modification that changes the protein’s charge and weakens its structure.
When MBP becomes citrullinated, the myelin layers loosen, electrical conduction slows, and the axon becomes far more vulnerable to demyelination.

➡️ MBP citrullination → myelin instability → demyelination → neurological decline.
This upstream biology is becoming an important area of research in understanding how MS progresses over time.

Quantum BioPharma is focused on advancing science in this space and exploring how targeted small molecules may support healthier myelin structure and function.

Understanding citrullination is key. Understanding demyelination is essential. Advancing research matters.
$QNTM

12/01/2025

Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC

https://www.globenewswire.com/news-release/2025/12/01/3196861/0/en/Investigative-News-Program-W5-Airs-Final-Segment-on-USD-700-Million-Stock-Market-Manipulation-Lawsuit-of-Quantum-Biopharma-Involving-CIBC-and-RBC.html

$QNTM

11/28/2025

Breakthroughs in MS don’t happen by accident — they happen when someone finally looks at the biology differently.

Most treatments in MS still revolve around the autoimmune narrative. But the science is shifting.
Demyelination has a biochemical signature: citrullination.

When myelin proteins become over-citrullinated, the sheath weakens, repair fails, and disease progression accelerates.

That’s why Lucid-MS stands out. It’s a new chemical entity built around the neurodegenerative side of MS — the part traditional drugs don’t touch.

Strong research deserves a fair environment to advance.

MS patients need real innovation. And the biology behind this one is worth paying attention to.

Learn More at https://quantumbiopharma.com/lucid-ms

$QNTM

11/27/2025

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC

Thank you CTV News & Reporter Jon Woodward for the extensive coverage on these topics.

https://www.globenewswire.com/news-release/2025/11/27/3195939/0/en/Award-winning-Investigative-News-Program-W5-Airs-Part-2-of-3-part-Television-Series-on-Alleged-Stock-Market-Manipulation-of-Quantum-Biopharma-Involving-Two-of-Canada-s-Largest-Bank.html

$QNTM

11/27/2025

Thanks CTV News & W5's Investigative Journalism for taking the time to cover Quantum BioPharma’s story and for digging deeply into the alleged market-manipulation issues. $QNTM

W5's Jon Woodward () investigates the rise of stock spoofing and the push within Canada for steeper penalties to take the profit out of the rapidly evolving tactic.

$QNTM

11/27/2025

CTV News Tik Tok Coverage on Quantum Biopharma $QNTM talking about MS and Spoofing allegations.

https://vt.tiktok.com/ZSfmjC94t/

11/26/2025

Did 'stock spoofing' nearly sink a Toronto-based company's promising MS treatment?

W5's Jon Woodward investigates 'stock spoofing,' a market manipulation tactic that Quantum BioPharma claims nearly wiped out the company's share price.Subscr...

11/26/2025

Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

https://www.globenewswire.com/news-release/2025/11/25/3194699/0/en/quantum-biopharma-s-usd-700-million-lawsuit-alleging-stock-market-manipulation-subject-of-3-part-series-investigative-news-program-w5.html

$QNTM

11/26/2025

CTV National News Inside Quantum BioPharma’s $700M Spoofing Case and MS Research Efforts

Live On-Air recording by CTV News () W5 investigative journalist Jon Woodward () exploring whether a Canadian company’s Multiple Sclerosis research was nearly derailed by alleged market manipulation.

https://youtu.be/-RX3-af3NGc

$QNTM

11/25/2025

CTV News CTV News Reporting: Quantum BioPharma $QNTM

Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?

This is part one of a W5 investigation into the phenomenon of “stock spoofing,” a market manipulation tactic that a Canadian biotech company says nearly derailed a promising medical treatment.

W5's Jon Woodward reports on the collapse of the share price of Toronto-based Quantum BioPharma and the $700M legal battle it sparked.

CTV News

11/25/2025

CTV News

Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?

This is part one of a W5 investigation into the phenomenon of “stock spoofing,” a market manipulation tactic that a Canadian biotech company says nearly derailed a promising medical treatment.

W5's Jon Woodward reports on the collapse of the share price of Toronto-based Quantum BioPharma and the $700M legal battle it sparked.

https://ctvnews.ca/business/article/was-a-canadian-companys-multiple-sclerosis-research-nearly-derailed-by-market-manipulation

$QNTM

Part one of a W5 investigation into the phenomenon of “stock spoofing,” a market manipulation tactic that a Canadian biotech company says nearly derailed a promising medical treatment.